GSK Poaches New Vaccines R&D Chief From Pfizer

Looking To Close Gap On mRNA Leaders

 
• By Andrew McConaghie
  
GSK vaccines
GSK's vaccines division earned £7bn ($9.31bn) last year, but is facing competition, not least from Pfizer/BioNTech and Moderna's mRNA breakthrough. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip